NEW YORK (TheStreet) -- Assessing whether a stock is a "value play" or a "value trap" has become a popular hobby for financial writers. Although some companies may deserve bullish considerations on the basis on their own performances, some have to be

Stryker performed well enough this past quarter, but Edwards Lifesciences' fall is another blow to the struggling industry this season.

By Stephen Simpson:With a majority of the major orthopedic and medical technology companies having reported now, it's pretty clear that key markets like orthopedics and surgery are still seeing pretty sluggish performance. Yet the stocks of companies

Stryker (SYK)Q1 2013 Earnings CallApril 24, 20134:30 pm ETExecutivesKevin A. Lobo - Chief Executive Officer, President and DirectorKatherine A. Owen - Vice President of Strategy & Investor RelationsDean H. Bergy - Vice President and SecretaryAnalysts

Here's your Cheat Sheet to earnings...

ByEmerging Equities:Times are challenging for companies in the medtech industry with the introduction of the Affordable Care Act's medical device excise tax, pricing pressures and the maturation of certain segments of the industry. Growth is becoming

Stryker Corporation (NYSE: SYK)announced today that its orthopaedic division has received notice that theU.S.

April 8 (Reuters) - Medical products maker Stryker Corp on Monday named William Jellison as chief financial officer, replacing Dean Bergy, who was interim CFO.

April 8 (Reuters) - Medical products maker Stryker Corp on Monday said it named William Jellison chief financial officer, replacing Dean Bergy, who was serving as interim CFO.

April 8 (Reuters) - Medical products maker Stryker Corp on Monday said it named William Jellison chief financial officer, replacing Dean Bergy, who was serving as interim CFO.

NEW YORK (F.A.S.T. Graphs) -- As the stock market continues to advance, it's getting harder and harder to find exciting investments at fair values. However, regardless of whether the overall market is high or low, there are always bargains to be had.

Looking at the universe of stocks we cover at Dividend Channel, on 3/26/13, Stryker Corp. (NYSE: SYK) will trade ex-dividend, for its quarterly dividend of $0.265, payable on 4/30/13. As a percentage of SYK's recent stock price of $64.49, this d

The FDA said it has received additional death and injury reports involving certain Stryker surgical devices that never received agency approval.

March 12 (Reuters) - Orthopedic implant maker Stryker Corp said it received a warning letter from the U.S. Food andDrug Administration related to quality concerns at its Portage,Michigan facility.

Stryker Corporation (NYSE: SYK)announced today that its Instruments division has received a warning letterfrom the U.S.

ByNick Chiu:In this article, two healthcare stocks, Illumina, Inc. (ILMN) and Stryker Corporation (SYK) with positive catalysts will be presented. Both stocks will be analyzed fundamentally and technically. Investing strategies will also be reviewed.

The most recent short interest data has been released by the NASDAQ for the 02/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." Th

Stryker Corporation (NYSE: SYK) announced today the successful completion of its previously announced voluntary general offer to acquire Trauson Holdings Company Limited (Trauson). Trauson is the leading trauma manufacturer in China and a major compe

Stryker Corporation (SYK)February 25, 2013 10:20 am ETExecutivesKevin A. Lobo - Chief Executive Officer, President and DirectorKatherine A. Owen - Vice President of Strategy & Investor RelationsAnalystsMatthew J. Dodds - Citigroup Inc, Research Divis

By Daniel Lauchheimer:Last week saw a slew of huge M&A activity. Comcast (CMCSA) bought the remaining 49% of NBC still owned by GE (GE), US Airways (LCC) merged with a chapter 11 American Airlines (AAMRQ.PK), and finally Berkshire Hathaway (BRK.A) te

By David Russell, reporter atOptionMonsterNEW YORK -- Stryker pulled back after running hard in January, and now the bulls are looking for more upside. OptionMonster's tracking systems showed the purchase of some 2,100 March 65 calls for 60 cents. Vo

Credit Suisse downgraded Stryker Corporation (NYSE: SYK) from Outperform to Neutral.Credit Suisse said, "We're downgrading SYK to Neutral from Outperform following the stock's recent strong performance, which leaves < 10% upside relative to our un

By Peter Geschek:DividendStryker Corporation (SYK), a medical device maker, is paying a cash dividend of $0.265 per share scheduled for January 31, 2013. This is a 24.71% increase over the prior quarter payment of 21 cents. The ex-dividend date was o

By Stephen Simpson:Over the past year or so, investors have come back to the med-tech space and pushed valuations back up to levels closer to historical norms. Although that means a lot of easy money is gone, many of these companies still hold worthw

Stryker and St. Jude are two companies heading in opposite directions

Stryker (SYK)Q4 2012 Earnings CallJanuary 23, 20134:30 pm ETExecutivesKevin A. Lobo - Chief Executive Officer, President and DirectorKatherine A. Owen - Vice President of Strategy & Investor RelationsDean H. Bergy - Interim Chief Financial Officer, V

* Net earnings decrease 32.7 pct on charges for hip recall

SAN FRANCISCO (MarketWatch) -- Stryker Corp.on Wednesday reported fourth-quarter profit of $270 million, compared to $401 million in the same quarter last year. The firm reported per-share earnings of 71 cents, 32% lower than the year-ago quarter. Ad

Jan 23 (Reuters) - Orthopedic implant maker Stryker Corp on Wednesday reported quarterly earnings excludingcharges that exceeded analyst estimates as sales of its hip,knee and spine products improved.

By ChinaBio Today: Deals and FinancingsStryker Corporation (NYSE: SYK), a US medical device company, will acquire a China orthopedic maker, Trauson Holdings (HK: 0325), for $764 million in cash (see story). Trauson's major shareholder, Luna Group wi

Wall Street is expecting higher profit for Stryker (SYK) when the company reports its fourth quarter results on Wednesday, January 23, 2013. The consensus estimate is calling for profit of $1.13 a share, a rise from $1.02 per share a year ago.

Stryker offered to acquire spine-products maker Trauson Holdings for about $98.5 million, a deal that would expand the U.S. medical-device maker's presence in the large and fast-growing segment of the Chinese orthopedic market.

Jan 17 (Reuters) - Medical device maker Stryker Corp said it will buy Hong Kong-based Trauson Holdings Co Ltd for $764 million in cash to expand in China, one ofthe fastest-growing markets for orthopaedic products.

Jan 17 (Reuters) - Medical device maker Stryker Corp said it will buy Hong Kong-based Trauson Holdings Co Ltd for $764 million in an all cash deal, to expand in oneof the fastest-growing markets...

General Dynamics Corpsaid on Monday it notified 139 of its employees at the U.S. Army Depot in Anniston, Alabama last week that they face layoffs beginning in March due to a reduction in the company's production of Stryker armored vehicles.

WASHINGTON (Reuters) - General Dynamics Corpsaid on Monday it notified 139 of its employees at the U.S. Army Depot in Anniston, Alabama last week that they face layoffs beginning in March due to a reduction in the company's production of Stryker armo

General Dynamics Corpon Monday said it notified 139 of its employees at the U.S. Army Depot in Anniston, Alabama last week that they face layoffs beginning in March due to a reduction in the company's production of Stryker vehicles.

By Dividend Growth Investor:Stryker Corporation (SYK), together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The company is a member o

* Advises patients to see doctor even if there are noproblems

By greg group: Stryker Corporation (SYK) is a leading medical technology company that operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker remains committed to delivering incremental returns to investors by leve

Matthew Crews:Stryker (SYK) has historically been off my radar based on valuation. As a self-respecting value investor, it has been difficult to see the opportunity based on the premium the market has awarded Stryker over the years. The historical re

By Ingrid Hendershot: GLOBAL LEADERIn 1941, Dr. Homer Stryker, an orthopaedic surgeon from Kalamazoo, Michigan, founded the firm that bears his name. Stryker (SYK) is one of the world's leading medical technology companies, providing reconstructive,

By David Zanoni:Stryker Corporation (SYK) is a $21 billion large-cap global medical technology company. It operates in the following segments: Reconstructive, MedSurg, and Neurotechnology & Spine. The company offers products such as reconstructive or